Holen Sie sich die Stockscreener-App
0.6001
8.52%
-0.0559
Protagenic Therapeutics Inc Aktie (PTIX) Neueste Nachrichten
Protagenic Therapeutics faces Nasdaq delisting over equity deficit - Investing.com
PTIX stock touches 52-week low at $0.48 amid market challenges - Investing.com India
Protagenic Therapeutics Receives Delist Determination Letter from Nasdaq - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com India
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
ARMISTICE CAPITAL, LLC Acquires New Stake in Protagenic Therapeu - GuruFocus.com
Protagenic Therapeutics Inc. Warrant (PTIXW) Quarterly 10-Q Report - Quartz
Protagenic Therapeutics Inc. (PTIX) Quarterly 10-Q Report - Quartzy
Protagenic Therapeutics Completes Private Placement, Raises $1.275 Million - Defense World
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - AccessWire
Protagenic Therapeutics Raises $1.27M in Private Placement with Warrant Offerings | PTIX Stock News - StockTitan
Protagenic Therapeutics Raises $1.275M for Growth Initiatives - TipRanks
Protagenic Therapeutics Secures $1.275M in Private Placement - TipRanks
Protagenic Therapeutics announces $1.275 million stock sale By Investing.com - Investing.com Canada
Protagenic Therapeutics announces $1.275 million stock sale - Investing.com
Protagenic Therapeutics to sell 1.95M shares at 64c in private placement - TipRanks
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - AccessWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
PTIX stock touches 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa
PTIX stock touches 52-week low at $0.49 amid market challenges - Investing.com Canada
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Short Interest in Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Expands By 3,669.0% - Defense World
The Williams Companies, Inc. (NYSE:WMB) Shares Acquired by Mill Creek Capital Advisors LLC - Defense World
Stephens’s latest rating for PTLO stock - Knox Daily
Petratherm Ltd Reports Key Shareholder Changes - TipRanks
ProSiebenSat.1 Media (OTCMKTS:PBSFY) Shares Up 8.7% - Defense World
A look into Prothena Corporation plc (PRTA)’s deeper side - SETE News
Views of Wall Street’s Leading Experts on Proto Labs Inc - SETE News
Top Wall Street Forecasters Revamp Progress Software Price Expectations Ahead Of Q3 Earnings - Benzinga
Pacer Advisors Inc. Has $74.14 Million Stake in Playtika Holding Corp. (NASDAQ:PLTK) - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Rhumbline Advisers - Defense World
Protagonist Therapeutics Inc [NASDAQ: PTGX] Sees Increase in Stock Value - Knox Daily
Propel Hits 52-Week High on KOHO Link - Baystreet.ca
BOK Financial upgraded, Prosperity Bancshares downgraded at Truist (NASDAQ:BOKF) - Seeking Alpha
Roth/MKM flags Playtika stock’s profitability risks despite new IP additions - Investing.com Australia
Progyny Stock Faces Its Biggest Drop Ever After Losing a Major Client. Why These Analysts Like the Stock. - Barron's
Playtika (NASDAQ:PLTK) Rating Reiterated by Wedbush - Defense World
Progyny price target lowered to $25 from $37 at Cantor Fitzgerald - TipRanks
Acadian Asset Management LLC Sells 27,140 Shares of Proto Labs, Inc. (NYSE:PRLB) - Defense World
Morgan Stanley maintains positive outlook on ProLogis stock By Investing.com - Investing.com Canada
Investors who lost money with shares of Proto Labs, Inc. (NYSE: - openPR
Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms - BP Journal
Headlands Technologies LLC Sells 2,206 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Analyzing PTC Therapeutics Inc (PTCT) After Recent Trading Activity - Knox Daily
Check Out PTC Therapeutics Inc (PTCT)’s Trade Data Rather Than the Analysts’ Views - SETE News
A better buy-in window may exist right now for Protagonist Therapeutics Inc (PTGX) - SETE News
Bokf Na Raises Position in Kforce Inc. (NASDAQ:KFRC) - Defense World
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket - Benzinga
Needham & Company LLC Reiterates “Buy” Rating for Kornit Digital (NASDAQ:KRNT) - Defense World
Wall Street analysts’ outlook for Protagenic Therapeutics Inc (PTIX) - SETE News
Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Analyzing the Impact of Earnings Reports on Protagenic Therapeutics Inc Inc. (PTIX) Price Performance - The InvestChronicle
Protagenic Therapeutics (NASDAQ:PTIX) Stock Price Down 9.2% - Defense World
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):